The pipeline and future of drug development in schizophrenia

Abstract

While the current antipsychotic medications have profoundly impacted the treatment of schizophrenia over the past 50 years, the newer atypical antipsychotics have not fulfilled initial expectations, and enormous challenges remain in long-term treatment of this debilitating disease. In particular, improved treatment of the negative symptoms and cognitive… (More)
DOI: 10.1038/sj.mp.4002062

Topics

6 Figures and Tables

Slides referencing similar topics